Maine Pharmacists Eye Legislation to End Drug Plans' Retroactive Fees
Fri, 10 Mar 2017 00:00:00 -0500
Direct and indirect remuneration (DIR) fees are a "dragon" that pharmacists in Maine are trying to slay, says Felicity Homsted, chief pharmacy officer for Penobscot Community Health Care (PCHC) in Bangor and president of the Maine Society of Health-System Pharmacists (MSHP).
FDA Outlines Conditions for Pharmacies to Repackage Drug Products
A guidance issued by FDA on January 12 makes clear that the agency does not favor some long-standing habits of pharmacy personnel related to the repackaging of drug products.
Alabama Pharmacists Push for State Collaborative Therapy Law
The February 7 start of Alabama's 2017 legislative session is a fresh opportunity for the state to codify collaborative drug therapy management (CDTM) as part of pharmacy practice.
Abuse Potential of Noncontrolled Drugs Often Overlooked, Official Says
Mon, 27 Feb 2017 00:00:00 -0500
To get a real handle on drug abuse, clinicians need to look beyond opioids and consider the abuse potential of noncontrolled drugs, says Michael Cohen, operations officer for the investigations branch of the Department of Health and Human Services (HHS) Office of Inspector General (OIG) in Washington, D.C.
Pharmacists Turn Naloxone Training Programs into Video for Broad Audience
A pharmacy project to train emergency medical services (EMS) and law enforcement personnel in how to administer naloxone in cases of opioid overdose has grown into an educational effort that features a video aimed at any potential responder.